Abstract
Background: Epigallocatechin-3-gallate (EGCG) is an important pharmacological component in tea, and various effects, including anti-tumor, anti-inflammation, anti-aging, antiobesity, anti-diabetes, cardiovascular disease prevention and protection, immunoregulation, and neuroprotection, of this component have been confirmed. However, EGCG has been rarely used in clinical applications because of its poor stability and low bioavailability.
Objective: The work summarizes the characteristics about EGCG, describes its pharmacological mechanisms, explores the clinical availability of EGCG, and establishes a basis for EGCG preparations in clinical applications.
Conclusion: In addition to altering dosage forms or synthesizing analogs to overcome losses during absorption, inducing gauxiliary effect and enhancing chemosensitivity can be achieved by EGCG in a combined medication. The pharmacological action, pharmacology network, including mutation of signaling receptor and modulation of intracellular signaling pathway, and combination treatment strategy of EGCG are clarified and distinguished. Possible targets and combined applications based on the characteristics of EGCG are also systematically summarized. EGCG may be a candidate compound that maintains balance of the patient's disease progression and becomes suitable for clinical use in combination treatment.
Keywords: EGCG, auxiliary effect, enhancing chemosensitivity, combined medication, pharmacological action, pharmacology network.
Combinatorial Chemistry & High Throughput Screening
Title:Epigallocatechin-3-gallate(EGCG): Mechanisms and the Combined Applications
Volume: 20 Issue: 10
Author(s): Xuekun Song, Juan Du, Wenyuan Zhao and Zheng Guo*
Affiliation:
- College of Bioinformatics Science and Technology, Harbin Medical University, Harbin,China
Keywords: EGCG, auxiliary effect, enhancing chemosensitivity, combined medication, pharmacological action, pharmacology network.
Abstract: Background: Epigallocatechin-3-gallate (EGCG) is an important pharmacological component in tea, and various effects, including anti-tumor, anti-inflammation, anti-aging, antiobesity, anti-diabetes, cardiovascular disease prevention and protection, immunoregulation, and neuroprotection, of this component have been confirmed. However, EGCG has been rarely used in clinical applications because of its poor stability and low bioavailability.
Objective: The work summarizes the characteristics about EGCG, describes its pharmacological mechanisms, explores the clinical availability of EGCG, and establishes a basis for EGCG preparations in clinical applications.
Conclusion: In addition to altering dosage forms or synthesizing analogs to overcome losses during absorption, inducing gauxiliary effect and enhancing chemosensitivity can be achieved by EGCG in a combined medication. The pharmacological action, pharmacology network, including mutation of signaling receptor and modulation of intracellular signaling pathway, and combination treatment strategy of EGCG are clarified and distinguished. Possible targets and combined applications based on the characteristics of EGCG are also systematically summarized. EGCG may be a candidate compound that maintains balance of the patient's disease progression and becomes suitable for clinical use in combination treatment.
Export Options
About this article
Cite this article as:
Song Xuekun , Du Juan , Zhao Wenyuan and Guo Zheng *, Epigallocatechin-3-gallate(EGCG): Mechanisms and the Combined Applications, Combinatorial Chemistry & High Throughput Screening 2017; 20 (10) . https://dx.doi.org/10.2174/1386207321666171218115850
DOI https://dx.doi.org/10.2174/1386207321666171218115850 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
Call for Papers in Thematic Issues
Artificial Intelligence Methods for Biomedical, Biochemical and Bioinformatics Problems
Recently, a large number of technologies based on artificial intelligence have been developed and applied to solve a diverse range of problems in the areas of biomedical, biochemical and bioinformatics problems. By utilizing powerful computing resources and massive amounts of data, methods based on artificial intelligence can significantly improve the ...read more
Eco-friendly Agents for Biological Control of Pathogenic Diseases
The discovery of an alternative biological approach to disease management includes work on medicinal products derived from natural sources as a starting point for the development of eco-friendly agents for these diseases and the injuries they cause, as well as reducing human contact with hazardous chemicals and their residues. We ...read more
Emerging trends in diseases mechanisms, noble drug targets and therapeutic strategies: focus on immunological and inflammatory disorders
Recently infectious and inflammatory diseases have been a key concern worldwide due to tremendous morbidity and mortality world Wide. Recent, nCOVID-9 pandemic is a good example for the emerging infectious disease outbreak. The world is facing many emerging and re-emerging diseases out breaks at present however, there is huge lack ...read more
Exploring Spectral Graph Theory in Combinatorial Chemistry
Scope of the Thematic Issue: Combinatorial chemistry involves the synthesis and analysis of a large number of diverse compounds simultaneously. Traditional methods rely on brute force experimentation, which can be time-consuming and resource-intensive. Spectral Graph Theory, a branch of mathematics dealing with the properties of graphs in relation to the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
SCYL1-BP1 Affects Cell Cycle Arrest in Human Hepatocellular Carcinoma Cells via Cyclin F and RRM2
Anti-Cancer Agents in Medicinal Chemistry In Silico and In Vitro Analysis of a Multiepitope L1-E7 Fusion Construct for Vaccine Development Against Human Papillomaviruses
Letters in Drug Design & Discovery HIF-1 Inhibitors for Cancer Therapy: From Gene Expression to Drug Discovery
Current Pharmaceutical Design Immunotherapeutic Options for Pediatric Malignancies
Current Immunology Reviews (Discontinued) Effects of Diet-Derived Molecules on the Tumor Microenvironment
Current Angiogenesis (Discontinued) Autophagy as a Molecular Target of Flavonoids Underlying their Protective Effects in Human Disease
Current Medicinal Chemistry Pyramidatine (Z88) Sensitizes Vincristine-Resistant Human Oral Cancer (KB/VCR) Cells to Chemotherapeutic Agents by Inhibition of P-glycoprotein
Anti-Cancer Agents in Medicinal Chemistry Purification and Characterization of a Lectin of the Swartzieae Legume Taxa
Protein & Peptide Letters Natural Products as Leads for Tuberculosis Drug Development
Current Topics in Medicinal Chemistry Bothrops pauloensis Snake Venom Toxins: The Search for New Therapeutic Models
Current Topics in Medicinal Chemistry HDAC as a Therapeutic Target for Treatment of Endometrial Cancers
Current Pharmaceutical Design Protein Knockdown Technology: Application of Ubiquitin Ligase to Cancer Therapy
Current Cancer Drug Targets Targeting Basal-Like Breast Cancers
Current Drug Targets Circulating Biomarkers for Tumor Angiogenesis: Where Are We?
Current Medicinal Chemistry Seek and Destroy: The Use of Natural Compounds for Targeting the Molecular Roots of Cancer
Current Drug Targets The Roles of Chromatin Remodeling Proteins in Cancer
Current Protein & Peptide Science Curcumin Sensitizes Cancers Towards TRAIL-induced Apoptosis via Extrinsic and Intrinsic Apoptotic Pathways
Current Drug Targets Recent Advances in Physical Delivery Enhancement of Topical Drugs
Current Pharmaceutical Design The Functions of Polo-Like Kinases and their Relevance to Human Disease
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Peptides in Oral Diseases
Current Pharmaceutical Design